NCT01688583View on ClinicalTrials.gov

The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement

CompletedOBSERVATIONAL

Enrollment

410

Participants

Timeline

Start Date

December 31, 2011

Primary Completion Date

March 31, 2013

Study Completion Date

March 31, 2013

Conditions

Chronic Pain

Interventions

DRUG

Fentanyl matrix

Dose will be adjusted in accordance with patient's degree of pain and treatment response in the investigator's judgment.

Trial Locations (11)

Unknown

Andong

Busan

Daegu

Daejeon

Goyang

Incheon

Jeonju

Kwangiu

Kwanju

Seoul

Wŏnju

All Listed Sponsors

lead

Janssen Korea, Ltd., Korea

INDUSTRY

NCT01688583 - The Effectiveness and Tolerability of Fentanyl Matrix in Chronic Non-cancer Pain; Assessment of Patient's Pain Treatment Goal Achievement | Biotech Hunter | Biotech Hunter